(Bloomberg) -- The U.S. Food and Drug Administration is turning to a patient-networking website to get a better handle on the side effects of medications.
The FDA is tapping into a broad flow of data sent to PatientsLikeMe, an online site with 350,000 members that says it’s the largest and most active patient network online. Members often report their drug-use experiences, symptoms, and hospitalizations on the site.
The agency said it hopes to learn more about side effects that might look harmless to a government drug reviewer but are troublesome to patients. Although the research is in the exploratory phase, it carries potential for influencing changes in drug labeling or how fast the agency might react to a safety issue.
Recommended For You
Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.
Your access to unlimited BenefitsPRO content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2025 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
